In vitro and three different patient cohorts validation analyses corroborated these findings.<h4>Conclusions</h4>Immune gene signature sets associated with TP53 status and co-mutations classify with more accuracy HNSCC patients. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.